Terms: = Breast cancer AND MLLT3, AF9, 4300, ENSG00000171843, P42568, YEATS3, AF-9
22 results:
1. The miR-5694/af9/Snail Axis Provides Metastatic Advantages and a Therapeutic Target in Basal-like breast cancer.
Tian X; Yu H; Li D; Jin G; Dai S; Gong P; Kong C; Wang X
Mol Ther; 2021 Mar; 29(3):1239-1257. PubMed ID: 33221433
[TBL] [Abstract] [Full Text] [Related]
2. BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese.
Ko JM; Ning L; Zhao XK; Chai AWY; Lei LC; Choi SSA; Tao L; Law S; Kwong A; Lee NP; Chan KT; Lo A; Song X; Chen PN; Chang YL; Wang LD; Lung ML
Int J Cancer; 2020 Feb; 146(4):1042-1051. PubMed ID: 31396961
[TBL] [Abstract] [Full Text] [Related]
3. C-terminal BRE inhibits cellular proliferation and increases sensitivity to chemotherapeutic drugs of MLL-af9 acute myeloid leukemia cells.
Pun CC; Lee KK; Chui YL
Leuk Lymphoma; 2019 Dec; 60(12):3011-3019. PubMed ID: 31111759
[TBL] [Abstract] [Full Text] [Related]
4. Simultaneous Multislice Echo Planar Imaging for Accelerated Diffusion-Weighted Imaging of Malignant and Benign breast Lesions.
Ohlmeyer S; Laun FB; Palm T; Janka R; Weiland E; Uder M; Wenkel E
Invest Radiol; 2019 Aug; 54(8):524-530. PubMed ID: 30946181
[TBL] [Abstract] [Full Text] [Related]
5. Metabolic Discrimination of breast cancer Subtypes at the Single-Cell Level by Multiple Microextraction Coupled with Mass Spectrometry.
Wang R; Zhao H; Zhang X; Zhao X; Song Z; Ouyang J
Anal Chem; 2019 Mar; 91(5):3667-3674. PubMed ID: 30702862
[TBL] [Abstract] [Full Text] [Related]
6. miR-564 inhibited metastasis and proliferation of prostate cancer by targeting mllt3.
Meng FJ; Meng FM; Wu HX; Cao XF
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4828-4834. PubMed ID: 29164580
[TBL] [Abstract] [Full Text] [Related]
7. Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
Chandler MR; Keene KS; Tuomela JM; Forero-Torres A; Desmond R; Vuopala KS; Harris KW; Merner ND; Selander KS
PLoS One; 2017; 12(9):e0183832. PubMed ID: 28886076
[TBL] [Abstract] [Full Text] [Related]
8. [Refractory primary myeloid sarcoma of the breast with MLL-af9 rearrangement].
Uchida E; Watanabe K; Oshikawa G; Sakashita C; Kurosu T; Fukuda T; Arai A; Murakami N; Miura O; Yamamoto M
Rinsho Ketsueki; 2016 Jan; 57(1):47-51. PubMed ID: 26861104
[TBL] [Abstract] [Full Text] [Related]
9. Patterns of cancer care costs in a country with detailed individual data.
Blakely T; Atkinson J; Kvizhinadze G; Wilson N; Davies A; Clarke P
Med Care; 2015 Apr; 53(4):302-9. PubMed ID: 25749656
[TBL] [Abstract] [Full Text] [Related]
10. PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers.
Li Y; Chitnis N; Nakagawa H; Kita Y; Natsugoe S; Yang Y; Li Z; Wasik M; Klein-Szanto AJ; Rustgi AK; Diehl JA
Cancer Discov; 2015 Mar; 5(3):288-303. PubMed ID: 25582697
[TBL] [Abstract] [Full Text] [Related]
11. Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin.
Berge EO; Huun J; Lillehaug JR; Lønning PE; Knappskog S
Biochim Biophys Acta; 2013 Mar; 1830(3):2790-7. PubMed ID: 23246812
[TBL] [Abstract] [Full Text] [Related]
12. CKIT mutation in therapy-related acute myeloid leukemia with mllt3/MLL chimeric transcript from t(9;11)(p22;q23).
Jung CL; Kim HJ; Kim DH; Huh H; Song MJ; Kim SH
Ann Clin Lab Sci; 2011; 41(2):193-6. PubMed ID: 21844580
[TBL] [Abstract] [Full Text] [Related]
13. Acute myeloid leukemia with t(9;11)(p21-22;q23): common properties of dysregulated ras pathway signaling and genomic progression characterize de novo and therapy-related cases.
Chandra P; Luthra R; Zuo Z; Yao H; Ravandi F; Reddy N; Garcia-Manero G; Kantarjian H; Jones D
Am J Clin Pathol; 2010 May; 133(5):686-93. PubMed ID: 20395514
[TBL] [Abstract] [Full Text] [Related]
14. The direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis.
Golubovskaya VM; Zheng M; Zhang L; Li JL; Cance WG
BMC Cancer; 2009 Aug; 9():280. PubMed ID: 19671193
[TBL] [Abstract] [Full Text] [Related]
15. The prognostic impact of some cell cycle regulatory proteins in Egyptian breast cancer patients.
Kamel A; Mokhtar N; Elshakankiry N; Yassin D; Elnahass Y; Zakarya O; Elbasmy A; Elmetenawy W
J Egypt Natl Canc Inst; 2006 Jun; 18(2):93-102. PubMed ID: 17496933
[TBL] [Abstract] [Full Text] [Related]
16. CYP1A1 activation of aminoflavone leads to DNA damage in human tumor cell lines.
Pobst LJ; Ames MM
Cancer Chemother Pharmacol; 2006 May; 57(5):569-76. PubMed ID: 16096788
[TBL] [Abstract] [Full Text] [Related]
17. Personalized targeted mailing increases mammography among long-term noncompliant medicare beneficiaries: a randomized trial.
Harrison RV; Janz NK; Wolfe RA; Tedeschi PJ; Chernew M; Stross JK; Huang X; McMahon LF
Med Care; 2003 Mar; 41(3):375-85. PubMed ID: 12618641
[TBL] [Abstract] [Full Text] [Related]
18. Frequent detection of mutations in the 5' flanking region of the prostate-specific antigen gene in female breast cancer.
Tsuyuki D; Grass L; Diamandis EP
Eur J Cancer; 1997 Oct; 33(11):1851-4. PubMed ID: 9470845
[TBL] [Abstract] [Full Text] [Related]
19. Binding sites for adeno-associated virus Rep proteins within the human genome.
Wonderling RS; Owens RA
J Virol; 1997 Mar; 71(3):2528-34. PubMed ID: 9032395
[TBL] [Abstract] [Full Text] [Related]
20. [Development of a monoclonal antibody (af9) to human breast carcinoma].
Zeng W; Cai G; Cai M; Chen P; Wang C; Wei D; Chen G
Hua Xi Yi Ke Da Xue Xue Bao; 1994 Dec; 25(4):380-3. PubMed ID: 7744377
[TBL] [Abstract] [Full Text] [Related]
[Next]
